BicMag Study - Improving Mineral Buffering Capacity in Dialysis Patients

Starting soon · Not applicable

Conditions studied: End Stage Renal Disease

In brief

The BicMag study is a prospective, randomized, controlled cross-over study that aims to examine the potential additive effect of a dialysate enriched with both bicarbonate and magnesium on mineral buffering capacity in the blood of chronic hemodialysis patients.

Key facts

Study ID

NCT07663279

Run by

Elisabethinen Hospital

People needed

91

Starts

2026-10-01

Expected to finish

2029-12-01

Last updated by the study team

2026-06-23

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Age ≥ 18 years
• Prevalent patients (≥ 3 months) treated with thrice weekly hemodialysis or hemodiafiltration
• Dialysate calcium of 1.25 mmol/l

You may not qualify if…

• Inability to provide informed consent
• Currently participating in another investigational device or drug study or non-interventional study
• Dialysate calcium other than 1.25 mmol/l
• Parathyroidectomy planned during the study
• Elective living-donor kidney transplant scheduled during the study period
• Therapy with bisphosphonates within the past 12 months or denosumab within the past 6 months
• Pregnant or nursing (lactating) women

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.